Luts & Greenleigh Group’s Eli Lilly LLY Stock Holding History

Luts & Greenleigh Group’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.17M	Sell	1,011 -22	-2%	-$26K	0.85%	27
2026 Q2	$1.24M	Buy	1,033 +25	+2%	+$25.5K	0.94%	24
2026 Q1	$927K	Sell	1,008 -25	-2%	-$25.3K	0.73%	30
2025 Q4	$1.11M	Buy	1,033 +42	+4%	+$40.2K	0.94%	28
2025 Q3	$756K	Sell	991 -53	-5%	-$39.4K	0.68%	33
2025 Q2	$814K	Sell	1,044 -20	-2%	-$15.5K	0.78%	28
2025 Q1	$879K	Buy	1,064 +79	+8%	+$65.7K	0.87%	24
2024 Q4	$760K	Buy	985 +52	+6%	+$43.1K	0.75%	31
2024 Q3	$827K	Buy	933 +36	+4%	+$32.4K	0.79%	27
2024 Q2	$812K	Buy	+897	New	+$718K	0.84%	26
2023 Q4	$329K	Buy	565 +65	+13%	+$37.9K	0.42%	43
2023 Q3	$268K	Buy	+500	New	+$258K	0.33%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $104B AUM 51.65% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Luts & Greenleigh Group's LLY Position: Q3 2026 in Review

Luts & Greenleigh Group reduced its Eli Lilly (LLY) stake by 2.1% in Q3 2026, selling an estimated $26K and leaving 1,011 shares worth $1.17M. The position accounts for 0.85% of the portfolio, ranked #27.

Luts & Greenleigh Group first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $1.24M in Q2 2026. 2,846 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

Luts & Greenleigh Group held 1,011 shares of Eli Lilly worth $1.17M as of Q3 2026.
Luts & Greenleigh Group sold 22 Eli Lilly shares in Q3 2026, an estimated $26K.
Eli Lilly made up 0.85% of Luts & Greenleigh Group's portfolio in Q3 2026, its #27 holding.
Luts & Greenleigh Group first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
Luts & Greenleigh Group's Eli Lilly position peaked at $1.24M in Q2 2026.
2,846 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Luts & Greenleigh Group's 13F filing for Q3 2026, filed 5 Nov 2026.